Cresilon, Inc.
A Production Supervisor on the 2nd shift in the biotechnology manufacturing department oversees daily operations, manages staff, and ensures quality standards are met. The role involves coordinating production activities to meet safety, efficiency, and compliance goals.
Headquarters
Brooklyn, New York, United States
Company Size
51-200 employees
Founded
2010
Cresilon is a biomedical company that develops plant-based hemostatic gel technology capable of stopping traumatic and surgical bleeding in seconds without the need for manual pressure. Its products include TRAUMAGEL, a hemostatic gel for emergency medicine, military, and trauma hospital use, and VETIGEL, the first hemostatic gel in the veterinary market, used in over 65,000 procedures worldwide. Founded in Brooklyn, NY, Cresilon serves emergency medicine, defense, and animal health markets with its flowable hydrogel technology.
Cresilon Announces Poster Presentation on TRAUMAGEL Case Study at the 2025 Military Health System Research Symposium
Aug 4, 2025
Cresilon Receives Innovative Technology Contract from Vizient for TRAUMAGEL
1 week ago
Cresilon Announces International Distribution Agreement for VETIGEL with McCarthy Vet
Jun 16, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Cresilon, Inc..
Cresilon, Inc. didn’t post a salary, so this is our estimate from similar listings.
19% above the average for this role
Brooklyn company launches life-saving gel nationwide: 'Control bleeding almost instantly'
Apr 15, 2025